Benzinga's Top #PreMarket Gainers
March 26, 2015 at 08:19 AM EDT
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) shares gained 27.65% to $7.34 in the pre-market trading session on positive Phase 2 liver ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.